What is CHR Hansen?
Founded in 1874 and headquartered in Hoersholm, Denmark, CHR Hansen is a global bio-science leader. The company specializes in developing natural ingredient solutions that serve critical roles across the food, nutritional, pharmaceutical, and agricultural sectors. Its extensive history and focus on natural solutions position it as a key player in sustainable and health-conscious product development.
How much funding has CHR Hansen raised?
CHR Hansen has raised a total of $82M across 1 funding round:
Debt
$82M
Debt (2015): $82M with participation from The European Investment Bank
Key Investors in CHR Hansen
The European Investment Bank
The European Investment Bank (EIB) is the European Union's nonprofit long-term lending and finance institution, established in 1958 and headquartered in Luxembourg. It plays a crucial role in supporting EU policy objectives through strategic investments.
What's next for CHR Hansen?
The substantial enterprise-level funding, characterized as a major strategic investment, indicates CHR Hansen is poised for significant expansion and innovation. This capital injection will likely fuel advancements in research and development, enabling the company to further solidify its market leadership in natural ingredient solutions. Strategic partnerships and potential acquisitions may also be on the horizon as CHR Hansen leverages this financial backing to enhance its global reach and product portfolio.
See full CHR Hansen company page
